Secondary Logo

Journal Logo

February 2015 - Volume 37 - Issue 1
pp: 1-139


Erlotinib: Another Candidate for the Therapeutic Drug Monitoring of Targeted Therapy of Cancer? A Pharmacokinetic and Pharmacodynamic Systematic Review of Literature

Petit-Jean, Emilie; Buclin, Thierry; Guidi, Monia; More

Therapeutic Drug Monitoring. 37(1):2-21, February 2015.


Individualizing Oral Busulfan Dose After Using a Test Dose in Patients Undergoing Hematopoietic Stem Cell Transplantation: Pharmacokinetic Characterization

Effting, Cristiane; de Moraes Arantes, Adriano; Queiroz Labre, Luciana V.; More

Therapeutic Drug Monitoring. 37(1):66-70, February 2015.

Comparison of the Pharmacokinetics of Raltegravir Given at 2 Doses of 400 mg by Swallowing Versus One Dose of 800 mg by Chewing in Healthy Volunteers: A Randomized, Open-Label, 2-Period, Single-Dose, Crossover Phase 1 Study

Cattaneo, Dario; Cossu, Maria V.; Fucile, Serena; More

Therapeutic Drug Monitoring. 37(1):119-125, February 2015.